It has been an amazing experience working with #TeamRuby. And thanks to the leadership and energy of
Erin George, MD, experiments exploring new targeted therapy combos have already started. Can’t wait to see where this goes next! @mathonco.bsky.social @moffittnews.bsky.social

To read more: t.co/yLj3J7vSw9

Idea 3: strategies to mitigate chemotherapy-induced microbiome damage to empower adjuvant immunotherapy.

Idea 2: low dose targeted therapy combos, optimized via math models, to provide options for those patients who are not eligible for PARPis.

Idea 1: Better toxicity monitoring systems using AI and new fluctuating methylation clocks to assess bone marrow health.

Evolutionary theory tells us that to cure #ovariancancer we need to target it when its most vulnerable – at the end of 1st-line tx. The challenge: that’s also when treatment-induced toxicity is greatest.
Check out our new #IMO12 pre-print with 3 ideas how to tackle this! @mathonco.bsky.social

Attention #MathOnco friends! We'd like to put together a collage of pictures of the mathonco presence at #AACR25 for the #MathOnco newsletter. DM me yours by Monday (05/05) to see yours included.